Heron Therapeutics (HRTX) Q1 2023 Earnings

11MayConfirmed
Aug 22
Nov 22
Q4 2022
Q1 2023
-0.55
-0.42
-0.3
-0.17

Details

Expected EPS
-0.2
Actual EPS
-0.27
Surprise EPS
-0.07
Surprise Percent
+35%

Description

Heron Therapeutics (HRTX) has reported earnings of -0.27 per share for Q1 2023.

0 Comments

Share your thoughts